Merit Financial Group, LLC

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1621225 ALPHARETTA, GA

Position in VRTX

as of Jun 30, 2026 · filed Jul 20, 2026 Compact

Position Value

$6,069,041

+$1,454,054 QoQ

Shares Held

12,218

+18.2% QoQ

Ownership

0.005%

of shares outstanding

% of Portfolio

0.11%

of 13F equity value

Holder Rank

#441

of 1,735 holders

Holding Since

Mar 2023

14 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Merit Financial Group, LLC holds $38,062,980 across 57 Biotechnology names. VRTX ranks #1 (15.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma This page	12,218	$6,069,041
2	INCY	Incyte Corp	50,561	$5,731,591
3	EXEL	Exelixis, Inc.	84,634	$4,604,933
4	REGN	Regeneron Pharmaceuticals, Inc.	3,333	$2,078,255
5	MRNA	Moderna, Inc.	25,205	$1,765,104
6	JAZZ	Jazz Pharmaceuticals plc	5,380	$1,296,414
7	BMRN	Biomarin Pharmaceutical Inc	20,198	$1,155,727
8	CORT	Corcept Therapeutics Inc	11,908	$1,035,397

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$6,069,041	12,218	+18.2%	Shares	Other	2026-07-20
2026-03-31	$4,614,987	10,335	+15.3%	Shares	Other	2026-04-15
2025-12-31	$4,065,273	8,967	+47.3%	Shares	Other	2026-01-26
2025-09-30	$2,383,909	6,087	-2.8%	Shares	Other	2025-11-07
2025-06-30	$2,786,952	6,260	+15.3%	Shares	Sole	2025-07-22
2025-03-31	$2,631,118	5,427	+10.1%	Shares	Sole	2025-04-09
2024-12-31	$1,985,713	4,931	+77.6%	Shares	Sole	2025-01-15
2024-09-30	$1,291,062	2,776	-26.5%	Shares	Sole	2024-10-17
2024-06-30	$1,770,355	3,777	+10.0%	Shares	Sole	2024-08-13
2024-03-31	$1,435,864	3,435	+75.4%	Shares	Sole	2024-05-06
2023-12-31	$796,690	1,958	-46.4%	Shares	Sole	2024-02-06
2023-09-30	$1,271,337	3,656	-7.0%	Shares	Sole	2023-11-07
2023-06-30	$1,383,358	3,931	+140.6%	Shares	Sole	2023-08-01
2023-03-31	$514,824	1,634	—	Shares	Sole	2023-04-24
No filing history on record for this holder in this stock.